Navigation Links
Concord Medical to Report Second Quarter 2013 Financial Results on Aug 12, 2013
Date:8/1/2013

BEIJING, Aug 1, 2013 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical", or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced the Company will release its financial results for the second quarter of 2013 after the market closes, at 6:00 pm EDT on Aug 12, 2013.

Management will hold a conference call to discuss the results the following day, at 8:00 am EDT on Aug 13, 2013 (8:00 pm in Beijing/Hong Kong on Aug 13, 2013).

The dial-in details for the live conference call are as follows:

U.S. Toll Free: 1 866 519 4004
U.K. Toll Free: 08082346646
International: 65 67239381
China Toll Free: 4006208038 / 8008190121
Hong Kong Toll Free: 800930346
Passcode: CCM

A replay of the conference call may be accessed by phone at the following numbers for 7 days:

U.S. Toll Free: 18554525696
International: +61 2 8199 0299
Conference ID: 26409831

Additionally, a live and archived webcast of the conference call will be available on the Investor Relations section of the Company's website at: http://ir.concordmedical.com/.

About Concord Medical

Concord Medical Services Holdings Limited operates the largest network of radiotherapy and diagnostic imaging centers in China, measured by revenues and the number of centers in operation. As of June 30, 2013, the Company operated a network of 140 centers with 77 hospital partners that spanned 53 cities and 24 provinces and administrative regions in China. Under long-term arrangements with top-tier hospitals in China, Concord Medical provides radiotherapy and diagnostic imaging equipment and manages the daily operations of these centers, which are located on the premises of its hospital partners. The Company also provides ongoing training to doctors and other medical professionals in its network of centers to ensure a high level of clinical care for patients. For more information, please see http://ir.concordmedical.com.

Investor and Media Contacts:

Concord Medical Services

Mr. Adam J. Sun
adam.sun@concordmedical.com
(+86) 10 5957-5266

Mr. Ting Jia
ting.jia@concordmedical.com
(+86) 10 5957-5270

ICR

In China:
Ms. Rene Jiang
Rene.Jiang@icrinc.com
(+86) 10 6583 7521

In the United States:
Mr. William Zima
William.Zima@icrinc.com
1-203-682-8233


'/>"/>
SOURCE Concord Medical Services Holdings Limited
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Concord Medical Announces Launch of Mobile Health Application
2. Concord Medical Reports First Quarter 2013 Financial Results
3. Concord Medical Announces the Signing of US$50 Million IFC Loan Agreement
4. Concord Medical to Report First Quarter 2013 Financial Results on May 21, 2013
5. Concord Medical Files 2012 Annual Report on Form 20-F with U.S. Securities and Exchange Commission
6. Concord Medical Reports Fourth Quarter and Full Year 2012 Financial Results
7. Concord Medical to Report Fourth Quarter and Full Year 2012 Financial Results on March 20, 2013
8. DDS Lab Announces Strategic Alliance with United Concordia
9. Concord Medical Acquires Ownership Interest in MD Anderson Cancer Center Proton Therapy Center
10. Concord Medical to Hold Annual General Meeting on December 22, 2012
11. Concord Medical Reports Third Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2017)... 13, 2017  Centurion Medical Products, a leader in medical product ... fecal impaction removal device for hospice patient care. ... Centurion Medical Products ... Patient pain management and emotional comfort are part ... alleviate patient pain while preventing unneeded emergency department admission due to ...
(Date:7/11/2017)... IRVINE, Calif. , July 11, 2017 Zymo Research Corp., ... new service that can quantify biological aging in a precise manner using ... Dr. Steve Horvath , a professor of human genetics and biostatistics ... Fielding School of Public Health , Zymo Research,s proprietary DNAge ™ ... loci. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... July 21, 2017 , ... Fresh Wave® IAQ today announced the launch ... for colleges and universities at the APPA 2017 Annual Conference and Exhibition ... tobacco smoke odors without the use of harsh chemicals, Fresh Wave IAQ Smoke Away ...
(Date:7/21/2017)... (PRWEB) , ... July 21, 2017 , ... The Margarian ... falsely advertising the contents of its ginger ale for allegedly containing no ginger. Dr. ... Dr. Pepper Snapple Group, Inc., plaintiff Gegham Margaryan alleges Canada Dry Ginger Ale claims ...
(Date:7/21/2017)... ... 21, 2017 , ... “Kids aren't born knowing how to regulate their emotions ... Tucker, Founder of St. Louis-based positive education company Generation Mindful. To help with that ... July 21st. , The kit uses colorful, engaging and educational illustrations and games ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... ligament (ACL) offer patients improved quality of life five years after injury, according ... Annual Meeting in Toronto, Ontario, Canada. The study followed patients for five ...
(Date:7/20/2017)... Boston, MA (PRWEB) , ... July 20, 2017 ... ... aggressive form of blood and bone marrow cancer that progresses rapidly without treatment. ... often recommended to reduce the chance of reoccurrence and relapse. With such ...
Breaking Medicine News(10 mins):